ASHLEY BASS: Open Payments
NPI 1194097444 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 66 payments from 18 companies in 2025. Trend: 2023 $836 · 2024 $1,084 · 2025 $1,668
Food & beverage: $1,669
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $302 |
| CVRx, Inc. | 4 | $171 |
| Merck Sharp & Dohme LLC | 9 | $166 |
| Novartis Pharmaceuticals Corporation | 8 | $141 |
| ABIOMED | 3 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $102 |
| PFIZER INC. | 5 | $99 |
| Actelion Pharmaceuticals US, Inc. | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Boston Scientific Corporation | 2 | $87 |
Products named: Barostim Neo System, FARXIGA, WAINUA, VERQUVO, LEQVIO, JARDIANCE, ELIQUIS, CAMZYOS.
Industry payments across SC — which companies pay providers there.
